TY - JOUR
T1 - Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry
AU - Berendsen, B.J.A.
AU - Wegh, R.S.
AU - Essers, M.L.
AU - Stolker, A.A.M.
AU - Weigel, S.
PY - 2012
Y1 - 2012
N2 - A liquid chromatography–tandem mass spectrometry method for the analysis of seven antiviral drugs, zanamivir, ribavirin, oseltamivir, oseltamivir carboxylate, amantadine, rimantadine and arbidol, in poultry muscle is reported. The antiviral drugs were extracted from the homogenized poultry muscle sample using methanol. The extract was purified using tandem solid-phase extraction combining a cation exchange cartridge and a phenylboronic acid cartridge. To prevent excessive matrix effects, the analytes were separated from the matrix constituents using a column-switch liquid chromatography system combining a reversed-phase and a Hypercarb analytical column. Detection was carried out using tandem mass spectrometry. The method was fully validated according to 2002/657/EC [1] and proved to be adequate for quantification and confirmation of zanamivir and ribavirin at 10 µg kg-1, oseltamivir, oseltamivir carboxylate, amantadine and rimantadine at levels below 1.0 µg kg-1 and for qualitative confirmatory analysis of arbidol at levels below 1 µg kg-1.
AB - A liquid chromatography–tandem mass spectrometry method for the analysis of seven antiviral drugs, zanamivir, ribavirin, oseltamivir, oseltamivir carboxylate, amantadine, rimantadine and arbidol, in poultry muscle is reported. The antiviral drugs were extracted from the homogenized poultry muscle sample using methanol. The extract was purified using tandem solid-phase extraction combining a cation exchange cartridge and a phenylboronic acid cartridge. To prevent excessive matrix effects, the analytes were separated from the matrix constituents using a column-switch liquid chromatography system combining a reversed-phase and a Hypercarb analytical column. Detection was carried out using tandem mass spectrometry. The method was fully validated according to 2002/657/EC [1] and proved to be adequate for quantification and confirmation of zanamivir and ribavirin at 10 µg kg-1, oseltamivir, oseltamivir carboxylate, amantadine and rimantadine at levels below 1.0 µg kg-1 and for qualitative confirmatory analysis of arbidol at levels below 1 µg kg-1.
KW - metabolite oseltamivir carboxylate
KW - solid-phase extraction
KW - influenza-a virus
KW - lc-ms/ms method
KW - human plasma
KW - rat plasma
KW - human serum
KW - resistance
KW - amantadine
KW - ribavirin
U2 - 10.1007/s00216-011-5581-3
DO - 10.1007/s00216-011-5581-3
M3 - Article
SN - 1618-2642
VL - 402
SP - 1611
EP - 1623
JO - Analytical and Bioanalytical Chemistry
JF - Analytical and Bioanalytical Chemistry
IS - 4
ER -